DC homeostasis in hematopoietic stem cell transplantation - PubMed (original) (raw)
Review
DC homeostasis in hematopoietic stem cell transplantation
M P Collin et al. Cytotherapy. 2007.
Abstract
Hematopoietic stem cell transplantation is an important experimental tool and therapeutic modality. Its efficacy and toxicity are both linked to a GvH reaction that is initiated by donor T cells recognizing recipient APC, of which DC are the most potent. In most tissues recipient DC are replaced after transplantation because they turnover rapidly from BM-derived precursors. However, in a number of sites, notably the skin, recipient DC may persist and even self-renew for many months after transplantation. Understanding the homeostasis of different APC populations and how they are related to the induction of alloreactivity may help to improve the therapeutic benefit of transplantation.
Similar articles
- Dendritic cell homeostasis and trafficking in transplantation.
Merad M, Collin M, Bromberg J. Merad M, et al. Trends Immunol. 2007 Aug;28(8):353-9. doi: 10.1016/j.it.2007.06.003. Epub 2007 Jul 6. Trends Immunol. 2007. PMID: 17618832 Review. - Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during priming.
Wang XN, Haniffa MA, Holtick U, Collin MP, Jackson G, Hilkens CM, Holler E, Edinger M, Hoffmann P, Dickinson AM. Wang XN, et al. Transplantation. 2009 Jul 27;88(2):188-97. doi: 10.1097/TP.0b013e3181ac14ce. Transplantation. 2009. PMID: 19623013 - Induction of recipient cell-specific donor T-cell anergy by UV-C-irradiated recipient immature monocyte-derived dendritic cells.
Tochiki N, Narita M, Zheng Z, Lu C, Saitoh A, Watanabe N, Satoh N, Furukawa T, Toba K, Fuse I, Aizawa Y, Takahashi M. Tochiki N, et al. Bone Marrow Transplant. 2008 Jun;41(12):1037-45. doi: 10.1038/bmt.2008.28. Epub 2008 Mar 10. Bone Marrow Transplant. 2008. PMID: 18332913 - NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation.
Ruggeri L, Mancusi A, Burchielli E, Capanni M, Carotti A, Aloisi T, Aversa F, Martelli MF, Velardi A. Ruggeri L, et al. Blood Cells Mol Dis. 2008 Jan-Feb;40(1):84-90. doi: 10.1016/j.bcmd.2007.06.029. Epub 2007 Oct 26. Blood Cells Mol Dis. 2008. PMID: 17964828 - Biological advances in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Duran-Struuck R, Reddy P. Duran-Struuck R, et al. Transplantation. 2008 Feb 15;85(3):303-8. doi: 10.1097/TP.0b013e318162d357. Transplantation. 2008. PMID: 18301323 Review.
Cited by
- Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation.
Hashimoto D, Chow A, Greter M, Saenger Y, Kwan WH, Leboeuf M, Ginhoux F, Ochando JC, Kunisaki Y, van Rooijen N, Liu C, Teshima T, Heeger PS, Stanley ER, Frenette PS, Merad M. Hashimoto D, et al. J Exp Med. 2011 May 9;208(5):1069-82. doi: 10.1084/jem.20101709. Epub 2011 May 2. J Exp Med. 2011. PMID: 21536742 Free PMC article. - A question of persistence: Langerhans cells and graft-versus-host disease.
Collin M, Jardine L. Collin M, et al. Exp Dermatol. 2014 Apr;23(4):234-5. doi: 10.1111/exd.12325. Exp Dermatol. 2014. PMID: 24443966 Free PMC article. - Differential rates of replacement of human dermal dendritic cells and macrophages during hematopoietic stem cell transplantation.
Haniffa M, Ginhoux F, Wang XN, Bigley V, Abel M, Dimmick I, Bullock S, Grisotto M, Booth T, Taub P, Hilkens C, Merad M, Collin M. Haniffa M, et al. J Exp Med. 2009 Feb 16;206(2):371-85. doi: 10.1084/jem.20081633. Epub 2009 Jan 26. J Exp Med. 2009. PMID: 19171766 Free PMC article. - Relapse after allogeneic stem cell transplantation.
Barrett AJ, Battiwalla M. Barrett AJ, et al. Expert Rev Hematol. 2010 Aug;3(4):429-41. doi: 10.1586/ehm.10.32. Expert Rev Hematol. 2010. PMID: 21083034 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources